Specific drugs for rare diseases in a province of eastern China under catalog management: from 2021 to 2023
The number of specific drugs for rare diseases has steadily increased, with the drug availability rate in Shandong Province reaching 80%. This indicates a generally high level of accessibility to drugs for rare diseases in China. However, attention should be given to improving the supply capacity for drugs that are in short supply and have a low delivery rate.
Authors
- Ruifang Nie (ORCID: https://orcid.org/0009-0007-7826-5550)
- Zhen Zhao (ORCID: https://orcid.org/0009-0002-1541-8517)
- Wen Zhang (ORCID: https://orcid.org/0009-0003-2702-845X)
- Bo Xu (ORCID: https://orcid.org/0000-0002-2919-3948)
- Yahui Zhang (ORCID: https://orcid.org/0000-0003-3281-9830)
Institutions
- Shandong Provincial Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-03-31
- DOI
- https://doi.org/10.3389/fphar.2025.1476910
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00